Page 41 - IJSA, Vol. 6, No 1, 2023

International Journal of Science Annals, Vol. 6, No. 1, 2023
рrint ISSN: 2617-2682; online ISSN: 2707-3637; DOI:10.26697/ijsa

Pavithran, P., Nandeesha, H., Madanmohan, B. Z., Walldius, G., Jungner, I., Holme, I., Aastveit, A. H.,
Sathiyapriya, V., Shenoy, P., Sunil, S., & Kolar, W., & Steiner, E. (2001). High
Shyma, P. (2007). Dyslipidemia antedates apolipoprotein B, low apolipoprotein A-I, and
occurrence of clinical hypertension in non- improvement in the prediction of fatal myocardial
diabetic, non-obese male subjects. Indian Journal infarction (AMORIS study): A prospective study.
of Physiology and Pharmacology, 51(1), 96–98. Lancet, 358(9298), 2026–2033.
https://www.ijpp.com/IJPP%20archives/2007_51 https://doi.org/10.1016/S0140-6736(01)07098-2
_1/96-98.pdf Williams, R. R., Hunt, S. C., Hopkins, P. N.,
Pyadala, N., Bobbiti, R. R., Borugadda, R., Bitinti, S., Stults, B. M., Wu, L. L., Hasstedt, S. J.,
Maity, S. N., Mallepaddi, P. C., & Polavarapu, R. Barlow, G. K., Stephenson, S. H., Lalouel, J. M.,
(2017). Assessment of lipid profile among & Kuida, H. (1988). Familial dyslipidemic
hypertensive patients attending to a rural teaching hypertension. Evidence from 58 Utah families for
hospital, Sangareddy. International Journal of a syndrome present in approximately 12% of
Medical Science and Public Health, 6, 71-74. patients with essential hypertension. JAMA,
https://doi.org/10.5455/ijmsph.2017.20062016559 259(24), 3579–3586.
Sabino, A. P., Sousa, M. De O., Lima, L. M., https://doi.org/10.1001/jama.259.24.3579
Ribeiro, D. D., Dusse, L. M., Carvalho, M. D. G., Yusuf, S., Hawken, S., Ounpuu, S., Dans, T.,
& Fernandes, A. P. (2008). ApoB/ApoA-I ratio in Avezum, A., Lanas, F., McQueen, M., Budaj, A.,
young patients with ischemic cerebral stroke or Pais, P., Varigos, J., & Lisheng, L. (2004). Effect
peripheral arterial disease. Translational of potentially modifiable risk factors associated
Research: The Journal of Laboratory and with myocardial infarction in 52 countries (the
Clinical Medicine, 152(3), 113–118. INTERHEART study): Case-control study.
https://doi.org/10.1016/j.trsl.2008.06.005 Lancet, 364(9438), 937–952.
Sur, A., Tirkey, B. N., & Mishra, P. K. (2015). https://doi.org/10.1016/S0140-6736(04)17018-9
Evaluation of role of serum lipoprotein and lipid Zhou, M. S., Liu, C., Tian, R., Nishiyama, A., & Raij, L.
profile in essential hypertension patients in a (2015). Skeletal muscle insulin resistance in salt-
tertiary care hospital. Journal of Hypertension, 4, sensitive hypertension: role of angiotensin II
204. https://doi.org/10.4172/2167-1095.1000204 activation of NFκB. Cardiovascular Diabetology,
14, 45. https://doi.org/10.1186/s12933-015-0211-6

Cite this article as:
Dubey, R., Baghel, D. S., Gaikwad, K., Rathore, V., Saxena, R., & Ansari, Y. M. (2023). Role of lipid profile,
apolipoproteins, and their ratio for prediction of cardiovascular disease in essential hypertension. International Journal
of Science Annals, 6(1), 32–39. https://doi.org/10.26697/ijsa.2023.1.3

The electronic version of this article is complete. It can be found online in the IJSA Archive
https://ijsa.culturehealth.org/en/arhiv

This is an Open Access article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited (http://creativecommons.org/licenses/by/4.0/deed.en).

39